SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-008442
Filing Date
2022-05-12
Accepted
2022-05-12 07:45:19
Documents
14
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K akus-20220512x8k.htm   iXBRL 8-K 41050
2 EX-99.1 akus-20220512xex99d1.htm EX-99.1 70325
3 GRAPHIC akus-20220512xex99d1001.jpg GRAPHIC 4968
  Complete submission text file 0001558370-22-008442.txt   250993

Data Files

Seq Description Document Type Size
4 EX-101.SCH akus-20220512.xsd EX-101.SCH 3033
5 EX-101.LAB akus-20220512_lab.xml EX-101.LAB 16586
6 EX-101.PRE akus-20220512_pre.xml EX-101.PRE 10715
8 EXTRACTED XBRL INSTANCE DOCUMENT akus-20220512x8k_htm.xml XML 5034
Mailing Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210
Business Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210 857-410-1818
Akouos, Inc. (Filer) CIK: 0001722271 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39343 | Film No.: 22915755
SIC: 2834 Pharmaceutical Preparations